Your Complete Guide to Global Clinical Research and GCP Compliance
Workflow and SOP Design to Operationalize Logistics: Direct-to-Patient IP & Kitting at Scale Workflow and SOP Design to Operationalize Logistics: Direct-to-Patient IP & Kitting at Scale In recent years, the evolution of clinical trials has shifted toward decentralized and hybrid models, significantly improving patient engagement and data collection. This article provides a step-by-step guide on…
KRIs, KPIs and Dashboards to Monitor Logistics: Direct-to-Patient IP & Kitting Performance KRIs, KPIs and Dashboards to Monitor Logistics: Direct-to-Patient IP & Kitting Performance The landscape of clinical trials is evolving, and with the rise of decentralized and hybrid clinical trials, the importance of effective logistics management has taken center stage. This comprehensive guide aims…
Case Studies: Logistics: Direct-to-Patient IP & Kitting That Improved Recruitment and Retention Case Studies: Logistics: Direct-to-Patient IP & Kitting That Improved Recruitment and Retention In the rapidly evolving landscape of clinical trials, particularly with the growing adoption of decentralized and hybrid models, understanding the logistical challenges associated with direct-to-patient Investigational Product (IP) delivery and kitting…
Patient-Centric Design Principles for Successful Logistics: Direct-to-Patient IP & Kitting Patient-Centric Design Principles for Successful Logistics: Direct-to-Patient IP & Kitting Introduction to Patient-Centric Logistics in Clinical Trials In the rapidly evolving landscape of clinical trials, the integration of patient-centric design principles into logistics processes has become paramount. With the shift towards decentralized and hybrid clinical…
Logistics: Direct-to-Patient IP & Kitting: Operating Blueprint for Scalable Decentralized Trials In the evolving landscape of clinical research, decentralized clinical trials (DCTs) have emerged as a pivotal methodology for increasing patient accessibility and enhancing trial efficiency. This comprehensive guide details the logistics behind direct-to-patient investigational product (IP) distribution and kitting in the framework of scalable…
How to Design Logistics: Direct-to-Patient IP & Kitting That Meets FDA, EMA and MHRA Expectations How to Design Logistics: Direct-to-Patient IP & Kitting That Meets FDA, EMA and MHRA Expectations In recent years, the landscape of clinical research has been evolving significantly, with decentralized and hybrid clinical trials leading the charge towards more patient-centric models….
Logistics: Direct-to-Patient IP & Kitting in Practice: Step-by-Step Guide for Sponsors and CROs Logistics: Direct-to-Patient IP & Kitting in Practice: Step-by-Step Guide for Sponsors and CROs As clinical trials evolve, logistics plays a critical role in the successful execution of decentralized and hybrid clinical trials. Direct-to-Patient (DtP) investigational product (IP) distribution and kitting can significantly…
Common Pitfalls in Logistics: Direct-to-Patient IP & Kitting—and How to Avoid Compliance Risks In an era where clinical trials increasingly embrace decentralized and hybrid models, understanding the intricacies of logistics concerning Investigational Product (IP) distribution and kitting is imperative. Particularly for organizations conducting astellas clinical trials, navigating these aspects is critical to ensuring compliance with…
Aligning Logistics: Direct-to-Patient IP & Kitting With GCP, Telehealth and Home-Based Care Regulations Aligning Logistics: Direct-to-Patient IP & Kitting With GCP, Telehealth and Home-Based Care Regulations As the landscape of clinical trials continues to evolve, particularly with the rise of decentralized and hybrid approaches, the logistical elements of trial management—including investigational product (IP) kitting and…
Vendor Oversight and Contracts for Technology-Heavy Telemedicine & Virtual Visits Vendor Oversight and Contracts for Technology-Heavy Telemedicine & Virtual Visits 1. Introduction to Vendor Oversight in Decentralized Clinical Trials The advent of telemedicine and virtual visits has transformed the landscape of clinical trials, particularly in decentralized and hybrid models. Vendor oversight is a critical component…
Read More “Vendor Oversight and Contracts for Technology-Heavy Telemedicine & Virtual Visits” »